U.S. Department of Justice
Press Release

Arizona Man Charged in Federal Court for Shipping Fentanyl to Racine

 

By - Feb 5th, 2024 12:35 pm

Gregory J. Haanstad, United States Attorney for the Eastern District of Wisconsin, announced that on February 1, 2024, Edgar Almonte (age: 27) was arrested in Phoenix, Arizona, based upon a criminal complaint alleging his involvement in shipping fentanyl via the U.S. postal service from Arizona to Racine, Wisconsin.

The criminal complaint alleges that Almonte sent over 20,000 fentanyl pills, or counterfeit Oxycodone Hydrochloride pills, and approximately 500 grams of pressed fentanyl to the Racine area, in violation of Title 21, United States Code, Sections 841(a)(1) and 841(b)(1)(A). If convicted of these charges, Almonte faces a mandatory 10 years of imprisonment and up to a lifetime term of imprisonment.

This case was investigated by the Federal Bureau of Investigation, Milwaukee Field Office, the Racine County Sheriff’s Office, and the Racine Police Department. The investigation was assisted by the Federal Bureau of Investigation, Phoenix Field Office, as well as the U.S. Attorney’s Office in the District of Arizona. It will be prosecuted by Assistant United States Attorney Elizabeth M. Monfils.

A criminal complaint is only a charge and is not evidence of guilt. The defendant is presumed innocent and is entitled to a fair trial at which the government must prove him guilty beyond a reasonable doubt.

NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. It has not been verified for its accuracy or completeness.

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us